Roger Jeffs

1.7k total citations
15 papers, 1.3k citations indexed

About

Roger Jeffs is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Roger Jeffs has authored 15 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Surgery. Recurrent topics in Roger Jeffs's work include Pulmonary Hypertension Research and Treatments (5 papers), Heart Failure Treatment and Management (4 papers) and Adenosine and Purinergic Signaling (3 papers). Roger Jeffs is often cited by papers focused on Pulmonary Hypertension Research and Treatments (5 papers), Heart Failure Treatment and Management (4 papers) and Adenosine and Purinergic Signaling (3 papers). Roger Jeffs collaborates with scholars based in United States, France and Belgium. Roger Jeffs's co-authors include Carl Arneson, Michael S. Wade, Nazzareno Galiè, Robert Naeije, Leona J. Rubin, Richard N. Channick, Vallerie V. McLaughlin, Ivan M. Robbins, Michael D. McGoon and Ronald J. Oudiz and has published in prestigious journals such as Journal of the American College of Cardiology, Biochemical Journal and Annals of the New York Academy of Sciences.

In The Last Decade

Roger Jeffs

15 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roger Jeffs United States 13 951 735 228 220 151 15 1.3k
Kirsty M. Mair United Kingdom 19 850 0.9× 365 0.5× 117 0.5× 86 0.4× 436 2.9× 23 1.4k
Gerrit Weimann Germany 11 1.4k 1.5× 1.2k 1.6× 127 0.6× 278 1.3× 214 1.4× 44 1.8k
DJ Stewart Canada 10 813 0.9× 478 0.7× 122 0.5× 143 0.7× 180 1.2× 15 1.2k
Valérie Nadeau Canada 16 554 0.6× 250 0.3× 122 0.5× 35 0.2× 463 3.1× 28 976
Laurel Wright United States 7 829 0.9× 405 0.6× 142 0.6× 124 0.6× 134 0.9× 9 991
Loı̈c Perchenet Switzerland 17 1.8k 1.9× 1.5k 2.0× 149 0.7× 348 1.6× 295 2.0× 44 2.3k
Gisselle Carvajal Spain 10 126 0.1× 233 0.3× 162 0.7× 46 0.2× 551 3.6× 11 1.1k
Chris Happé Netherlands 15 717 0.8× 525 0.7× 100 0.4× 64 0.3× 208 1.4× 21 941
Matthew J. Lovell United Kingdom 14 109 0.1× 263 0.4× 228 1.0× 65 0.3× 245 1.6× 21 871
Yoshiteru Morio Japan 16 544 0.6× 197 0.3× 130 0.6× 55 0.3× 265 1.8× 41 940

Countries citing papers authored by Roger Jeffs

Since Specialization
Citations

This map shows the geographic impact of Roger Jeffs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Jeffs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Jeffs more than expected).

Fields of papers citing papers by Roger Jeffs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger Jeffs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Jeffs. The network helps show where Roger Jeffs may publish in the future.

Co-authorship network of co-authors of Roger Jeffs

This figure shows the co-authorship network connecting the top 25 collaborators of Roger Jeffs. A scholar is included among the top collaborators of Roger Jeffs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger Jeffs. Roger Jeffs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Zaccardelli, David, et al.. (2010). Stability and antimicrobial effectiveness of treprostinil sodium in Sterile Diluent for Flolan. International Journal of Clinical Practice. 64(7). 885–891. 16 indexed citations
2.
Sitbon, Olivier, Alessandra Manes, Xavier Jaïs, et al.. (2007). Rapid Switch From Intravenous Epoprostenol to Intravenous Treprostinil in Patients With Pulmonary Arterial Hypertension. Journal of Cardiovascular Pharmacology. 49(1). 1–5. 61 indexed citations
3.
Galiè, Nazzareno, et al.. (2006). Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil. European Respiratory Journal. 28(6). 1195–1203. 254 indexed citations
4.
Laliberte, Kevin, Carl Arneson, Roger Jeffs, Thomas L. Hunt, & Michael S. Wade. (2004). Pharmacokinetics and Steady-State Bioequivalence of Treprostinil Sodium (Remodulin®) Administered by the Intravenous and Subcutaneous Route to Normal Volunteers. Journal of Cardiovascular Pharmacology. 44(2). 209–214. 152 indexed citations
5.
Barst, Robyn J., Michael D. McGoon, Vallerie V. McLaughlin, et al.. (2003). Beraprost therapy for pulmonary arterial hypertension. Journal of the American College of Cardiology. 41(12). 2119–2125. 468 indexed citations
6.
Mohler, Emile R., William R. Hiatt, Jeffrey W. Olin, et al.. (2003). Treatment of intermittent claudication with beraprost sodium, an orally active prostaglandin I2analogue. Journal of the American College of Cardiology. 41(10). 1679–1686. 63 indexed citations
7.
Hussein, Ziad, Misba Beerahee, R. F. Grover, et al.. (1999). Pharmacokinetics of the nitric oxide synthase inhibitor --methylarginine hydrochloride in patients with septic shock. Clinical Pharmacology & Therapeutics. 65(1). 1–9. 19 indexed citations
8.
Gearhart, John P., Jacob Ben‐Chaim, Roger Jeffs, & Ross Sanders. (1995). Criteria for the prenatal diagnosis of classic bladder exstrophy. Obstetrics and Gynecology. 85(6). 961–964. 70 indexed citations
9.
Matsumura, Tae, Hiroyuki Yoshihara, Roger Jeffs, et al.. (1992). Hormones increase oxygen uptake in periportal and pericentral regions of the liver lobule. American Journal of Physiology-Gastrointestinal and Liver Physiology. 262(4). G645–G650. 14 indexed citations
10.
Jeffs, Roger, et al.. (1991). Solubilization of a guanine nucleotide-sensitive form of the P2Y-purinergic receptor.. Molecular Pharmacology. 40(1). 85–92. 8 indexed citations
11.
Harden, T. Kendall, et al.. (1990). Biochemical Properties of a P2Y‐Purinergic Receptor. Annals of the New York Academy of Sciences. 603(1). 256–266. 19 indexed citations
12.
Jeffs, Roger, Christy L. Cooper, José L. Boyer, & T K Harden. (1990). Solubilization of a Guanine Nucleotide‐Sensitive Form of the P2Y‐Purinergic Receptor from Turkey Erythrocyte Membranes. Annals of the New York Academy of Sciences. 603(1). 476–477. 1 indexed citations
13.
Hepler, John R., Roger Jeffs, William R. Huckle, et al.. (1990). Evidence that the epidermal growth factor receptor and non-tyrosine kinase hormone receptors stimulate phosphoinositide hydrolysis by independent pathways. Biochemical Journal. 270(2). 337–344. 27 indexed citations
14.
Jeffs, Roger, et al.. (1989). Effects of low extracellular chloride on dopamine release and the dopamine transporter.. Journal of Pharmacology and Experimental Therapeutics. 248(2). 644–653. 17 indexed citations
15.
Sibley, David R., Roger Jeffs, Kiefer W. Daniel, Ponnal Nambi, & Robert J. Lefkowitz. (1986). Phorbol diester treatment promotes enhanced adenylate cyclase activity in frog erythrocytes. Archives of Biochemistry and Biophysics. 244(1). 373–381. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026